Health and Fitness Health and Fitness
Thu, May 19, 2011
[ 04:00 AM ] - Market Wire
Repligen Receives FDA Approval to Initiate Phase .. f Potential Treatment for Spinal Muscular Atrophy
[ 04:00 AM ] - Market Wire
PolyMedix PMX-30063 Defensin-Mimetic Antibiotic C .. pound Shows Promising Activity for Oral Mucositis
[ 04:00 AM ] - Market Wire
Centric Health to Acquire Blue Water Surgical, Wi .. oping Centres to Expand its National Network of S
[ 03:30 AM ] - Market Wire
Enzon Announces Discontinuation of PEG-SN38 Progr .. Carcinoma in Light of Evolving Standards of Care
[ 12:32 AM ] - Market Wire
Study Provides Insight on Medtronic CoreValve® System Implants Through Subclavian Approach
Wed, May 18, 2011
[ 06:30 PM ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against Community Health Systems, Inc.
[ 04:16 PM ] - Market Wire
Zusammenarbeit zwischen Northwest Biotherapeutics .. elltherapie und Immunologie bei klinischen Studie
[ 03:17 PM ] - Market Wire
ZIOPHARM Oncology to Present Data at 2011 ASCO An .. Treatment Demonstrating Small Molecule-Controlled
[ 03:01 PM ] - Market Wire
Phase II Study Results Evaluating Effect of Olapa .. Survival in Serous Ovarian Cancer Announced Today
[ 03:00 PM ] - Market Wire
Clinical Data Evaluating AVEO Pharmaceuticalsa? T .. be Presented at the American Society of Clinical
[ 01:00 PM ] - Market Wire
Alkermes Reports Financial Results for Fiscal 201 .. d Provides Financial Expectations for Fiscal 2012
[ 01:00 PM ] - Market Wire
Fibrocell Science, Inc. Reports First Quarter 2011 Financial Results and Provides Business Update
[ 10:15 AM ] - Market Wire
Cannabis Science Announces Planned Thailand Busin .. nership and Clinical Trials for Medical Marijuana
[ 09:15 AM ] - Market Wire
Dyax Corp. to Present at the UBS Global Specialty Pharmaceuticals Conference
[ 06:58 AM ] - Market Wire
ZIOPHARM Oncology Announces Filing of Resale Registration Statement for Previous Private Placement
[ 06:45 AM ] - Market Wire
Israelisches Gesundheitsministerium genehmigt Nur .. rste klinische Studie mit adulter Stammzelltherap
[ 06:28 AM ] - Market Wire
Northwest Biotherapeutics y Fraunhofer Institute .. gy se asocian para ensayos clnicos y casos de uso
[ 06:27 AM ] - Market Wire
Nasce una collaborazione tra Northwest Biotherape .. di terapia cellulare e immunologia per la conduz
[ 06:27 AM ] - Market Wire
Northwest Biotherapeutics en het Fraunhofer Insti .. nologie werken samen voor klinische proeven en ge
[ 06:15 AM ] - Market Wire
Baxter to Present at Goldman Sachs 32nd Annual Global Healthcare Conference
[ 06:05 AM ] - Market Wire
New Study Uncovers Significant Potential Savings .. Radiology Benefits Management Program in Medicare
[ 06:00 AM ] - Market Wire
Curis to Present at the 2nd Annual ThinkEquity Healthcare Conference
[ 06:00 AM ] - Market Wire
Celldex Prices Public Offering of Common Stock
[ 05:00 AM ] - Market Wire
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
[ 04:30 AM ] - Market Wire
Thermo Fisher Scientific Acquires Leading UK Provider of Laboratory Specialty Products
[ 04:00 AM ] - Market Wire
Abiomed Reports Record Fiscal Fourth Quarter Revenue of $28.5 Million, up 24% over Prior Year
[ 04:00 AM ] - Market Wire
Northwest Biotherapeutics and the Fraunhofer Inst .. munology Are Partnering for Clinical Trials and C
[ 03:30 AM ] - Market Wire
Medtronic Resolute® Drug-Eluting Stent Offers St .. rformance in Diabetic Patients with Heart Disease
[ 03:00 AM ] - Market Wire
Exelixis Launches Online Summit Featuring Expert .. on Cancer Treatment Advances and ASCO Highlights
[ 12:03 AM ] - Market Wire
China Kanghui Holdings to Present at Morgan Stanleya?s 2ND Annual Hong Kong Investor Summit

China Kanghui Holdings to Present at Morgan Stanleya?s 2ND Annual Hong Kong Investor Summit


Published on 2011-05-18 01:00:50 - Market Wire
  Print publication without navigation


CHANGZHOU, China--([ BUSINESS WIRE ])--China Kanghui Holdings (NYSE: KH), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the company will present at Morgan Stanleya™s 2nd Annual Hong Kong Investor Summit on May 20, 2011 and meet with institutional investors throughout the day.

The summit will be held at the Morgan Stanley International Commerce Center, 1 Austin Road, West Kowloon, Hong Kong.

Investors interested in attending the summit and meeting with representatives from Kanghui, please contact a Morgan Stanley sales representative.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 24 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit[ www.kanghui.com ].

Contributing Sources